Chemotherapy-related amenorrhea in women with early breast cancer: The effect of paclitaxel or dose density
Abusief M, Missmer S, Ginsburg E, Weeks J, Winer E, Partridge A. Chemotherapy-related amenorrhea in women with early breast cancer: The effect of paclitaxel or dose density. Journal Of Clinical Oncology 2006, 24: 10506-10506. DOI: 10.1200/jco.2006.24.18_suppl.10506.Peer-Reviewed Original ResearchRisk of amenorrheaEarly breast cancerBreast cancerDDS therapyPremenopausal womenDana-Farber Cancer InstituteMultivariable logistic regression modelChemotherapy-related amenorrheaLikelihood of amenorrheaAddition of paclitaxelDose densityEffect of paclitaxelLogistic regression modelsAdjuvant chemotherapyTamoxifen useWomen's HospitalMultivariable modelMenstrual functioningAmenorrheaAverage ageCancer InstituteMenstrual dataPatientsAlcohol useTherapyStudy participants’ perceptions of the process and impact of receiving results of N9831
Partridge A, Wolff A, Marcom P, Kaufman P, Moore C, Lake D, Fleming G, Rugo H, Collyar D, Winer E. Study participants’ perceptions of the process and impact of receiving results of N9831. Journal Of Clinical Oncology 2006, 24: 518-518. DOI: 10.1200/jco.2006.24.18_suppl.518.Peer-Reviewed Original ResearchTrial participantsLarge cooperative group trialsPhase III trialsCooperative group trialsSubset of womenClinical trial participantsHealth care providersAdjuvant chemotherapyRecurrent diseaseIII trialsMultivariable analysisClinical trialsBreast cancerGroup trialsCare providersAverage ageFavorable responseClinical investigatorsPsychosocial supportPatientsWomenSubstantial proportionTrialsStudy resultsGreater satisfaction